| Literature DB >> 30799798 |
Wendy Alexander Tanod1,2, Uun Yanuhar1, Masteria Yunovilsa Putra3, Yenny Risjani1,4.
Abstract
BACKGROUND: As a marine organism, soft corals can be utilized to be various bioactive substances, especially terpenoids and steroids. The soft corals family which produces bioactive generally come from clavulariidae, alcyoniidae, nephtheidae and xeniidae family.Entities:
Keywords: Central Sulawesi; Nephthea; Sarcophyton; Sinularia; natural product; nitric oxide.
Year: 2019 PMID: 30799798 PMCID: PMC6700601 DOI: 10.2174/1871523018666190222115034
Source DB: PubMed Journal: Antiinflamm Antiallergy Agents Med Chem ISSN: 1871-5230
Phytochemical analysis of all soft corals crude extracts.
|
|
|
| |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
| Saponins | + | - | - | + | + | + | Stable foam formed for 15 minutes |
| Polyphenols (tannins) | + | + | + | + | - | + | Brown precipitate formed |
| Steroids | - | + | - | - | + | - | Green or blue colour produced (Lieberman-Buchard) |
| Triterpenoids | + | - | + | + | - | + | Brown or reddish-brown colour produced (Lieberman-Buchard) |
| Alkaloids | + | + | + | + | + | + | Orange precipitate formed (Dragendorff) |
| Flavonoids | + | - | - | - | + | - | Orange, pink or red colour produced |
+: Present; -: Absent.
Analysis of variance two-factor with replication ANOVA.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Sample | 0.221 | 9 | 0.025 | 1.194 | 0.351 | 2.393 |
| Columns | 0.978 | 1 | 0.978 | 47.476 | 0.000 | 4.351 |
| Interaction | 0.109 | 9 | 0.012 | 0.585 | 0.794 | 2.393 |
| Within | 0.412 | 20 | 0.021 | - | - | - |
| Total | 1.720 | 39 | - | - | - | - |
Inhibitory effects of SCC, SCE, and SCF partitioned extracts on LPS-induced NO production in Mice Peritoneal Macrophages cell. Extracts were tested at 5 - 20 mg/ml. Data are presented as the means ± SD.
|
|
| ||
|---|---|---|---|
|
|
|
| |
| Control with LPS | 163.38 ± 3.79 | ||
| Control without LPS | 6.00 ± 0.92 | ||
| SCC DCM | 4.85 ± 0.17 | 6.31 ± 0.21 | 6.08 ± 0.01 |
| SCC EtOAc | 6.48 ± 0.25 | 6.46 ± 0.38 | 6.62 ± 0.34 |
| SCC BuOH | 8.46 ± 0.17 | 5.15 ± 0.21 | 4.77 ± 0.21 |
| SCE DCM | 6.54 ± 0.32 | 6.38 ± 0.17 | 6.77 ± 0.17 |
| SCE EtOAc | 6.38 ± 0.32 | 6.92 ± 0.17 | 7.08 ± 0.21 |
| SCE BuOH | 4.62 ± 0.17 | 4.54 ± 0.01 | 6.38 ± 0.17 |
| SCF DCM | 6.08 ± 0.01 | 7.23 ± 0.27 | 6.54 ± 0.17 |
| SCF EtOAc | 5.07 ± 0.50 | 5.84 ± 0.66 | 7.97 ± 0.28 |
| SCF BuOH | 6.23 ± 0.34 | 6.62 ± 0.21 | 5.69 ± 0.27 |
The chemical constituents probabilities identified by GC-MS analysis of all crude extracts that were indicated as potentially anti-inflammatory.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
| ||||||
| Octacosane | C28H58 | 11.466 | 3.25 | 91 | NIST | [ |
|
| ||||||
| Cyclohexene, 6-ethenyl-6-methyl-1-(1-methylethyl)-3-(1-methylethylid | C15H24 | 4.745 | 0.55 | 90 | NIST | [ |
| Azulene, 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethylidene)-, (1S-cis)- | C15H24 | 5.957 | 0.53 | 93 | NIST | [ |
| 1,7,7-Trimethyl-2-vinylbicyclo[2.2.1]hept-2-ene | C12H18 | 6.334 | 4.72 | 90 | NIST | [ |
|
| ||||||
| Eicosane | C20H42 | 7.357 | 0.12 | 86 | NIST | [ |
| Nonacosane | C29H60 | 13.352 | 6.78 | 98 | NIST | [ |
| 21.525 | 3.92 | 96 | NIST | |||
| 14(β)-Pregnane | C21H36 | 14.398 | 0.87 | 95 | Wiley | [ |
| Octacosane | C28H58 | 17.450 | 6.39 | 99 | NIST | [ |
| Tricosane | C23H48 | 18.250 | 0.32 | 95 | NIST | [ |
| 19.227 | 1.21 | 93 | NIST | |||
|
| ||||||
| 14(β)-Pregnane | C21H36 | 6.997 | 0.11 | 99 | Wiley | [ |
| 15.758 | 0.77 | 96 | Wiley | |||
| 15.953 | 0.98 | 96 | Wiley | |||
| 17.302 | 0.83 | 97 | Wiley | |||
| Octadecane | C18H38 | 10.798 | 13.06 | 95 | NIST | [ |
| 18.273 | 9.27 | 97 | NIST | |||
| 21.977 | 5.10 | 95 | NIST | |||
|
| ||||||
| Oleic Acid | C18H34O2 | 7.351 | 0.63 | 86 | NIST | [ |
| 7,10-Hexadecadienoic acid, methyl ester | C17H30O2 | 8.740 | 0.54 | 90 | NIST | [ |
| 14(β)-Pregnane | C21H36 | 10.752 | 0.36 | 97 | Wiley | [ |
| 17.296 | 0.71 | 95 | Wiley | |||
| 5,8,11,14-Eicosatetraenoic acid, ethyl ester, (all-Z)- | C22H36O2 | 12.381 | 4.60 | 95 | NIST | [ |
| Octacosane | C28H58 | 18.256 | 7.75 | 91 | NIST | [ |
| 1,2-Benzisothiazole, 3-(hexahydro-1H-azepin-1-yl)-, 1,1-dioxide | C13H16N2O2S | 18.759 | 1.23 | 91 | NIST | [ |
|
| ||||||
| Oxirane, decyl- | C12H24O | 10.003 | 1.38 | 92 | NIST | [ |
| Nonacosane | C29H60 | 10.363 | 0.13 | 94 | NIST | [ |
| 12.346 | 0.44 | 90 | NIST | |||
| Cyclohexanol, 5-methyl-2-(1-methylethenyl)- | C10H18O | 10.906 | 0.61 | 86 | NIST | [ |
| 14(β)-Pregnane | C21H36 | 11.060 | 0.26 | 90 | Wiley | [ |
| 11.969 | 0.50 | 86 | Wiley | |||
| Tetratriacontane | C34H70 | 13.678 | 1.02 | 95 | NIST | [ |
The chemical constituents Probabilities identified by GC-MS analysis of all crude extracts that were indicated as cytotoxic.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
| ||||||
| Heptadecanoic acid, 16-methyl-, | C19H38O2 | 10.969 | 1.60 | 93 | NIST | [ |
| 1-Hexacosene | C26H52 | 11.792 | 2.52 | 97 | NIST | |
| 13.346 | 0.75 | 92 | NIST | |||
| Tricosane | C23H48 | 12.089 | 2.16 | 90 | NIST | [ |
| 12.232 | 3.55 | 91 | NIST | |||
| 13.581 | 1.45 | 91 | NIST | |||
| 14.175 | 0.82 | 95 | NIST | |||
| 14.838 | 9.62 | 95 | NIST | |||
| 15.044 | 0.44 | 96 | NIST | |||
| 15.947 | 0.47 | 90 | NIST | |||
|
| ||||||
| Cyclohexane, 1-ethenyl-1-methyl-2, 4-bis(1-methylethenyl)- [1S-(1.al | C15H24 | 3.836 | 1.30 | 90 | NIST | [ |
| (-)-Aristolene | C15H24 | 4.185 | 0.68 | 99 | NIST | [ |
| Hexadecanoic acid, methyl ester | C17H34O2 | 9.060 | 1.22 | 97 | NIST | [ |
| .beta.-caryophyllene | C15H24 | 9.226 | 0.34 | 92 | Wiley | [ |
| Octadecanoic acid, methyl ester | C19H38O2 | 10.969 | 0.52 | 97 | NIST | [ |
| Octadec-9-enoic acid | C18H34O2 | 11.106 | 0.97 | 99 | NIST | [ |
| 5,8,11,14-Eicosatetraenoic acid, ethyl ester, (all-Z)- | C22H36O2 | 12.386 | 3.31 | 94 | NIST | [ |
|
| ||||||
| 9,17-Octadecadienal, (Z)- | C18H32O | 8.334 | 0.14 | 92 | NIST | [ |
| Hexadecanoic acid, methyl ester | C17H34O2 | 9.054 | 1.06 | 95 | NIST | [ |
| 1-Hexacosene | C26H52 | 12.781 | 0.86 | 94 | NIST | [ |
| Tricosane | C23H48 | 12.935 | 1.53 | 96 | NIST | [ |
| 13.164 | 1.87 | 92 | NIST | |||
|
| ||||||
| Cyclohexane, 1-ethenyl-1-methyl-2, 4-bis(1-methylethenyl)- [1S-(1.al | C15H24 | 3.836 | 0.71 | 98 | NIST | [ |
| 9.654 | 1.01 | 89 | NIST | |||
| 7-Pentadecyne | C15H28 | 9.134 | 0.94 | 98 | NIST | [ |
| Tricosane | C23H48 | 12.986 | 2.86 | 91 | NIST | [ |
| 1-Hexacosene | C26H52 | 14.061 | 0.76 | 94 | NIST | [ |
| 17.181 | 1.50 | 90 | NIST | |||
| 20.302 | 0.18 | 95 | NIST | |||
|
| ||||||
| Acetamide, N-methyl-N-[4-[4-methoxy-1-hexahydropyridyl]-2-butynyl]- | C13H22N2O2 | 9.060 | 0.25 | 91 | Wiley | [ |
| n-Eicosane | C20H42 | 10.980 | 0.41 | 93 | Wiley | [ |
| Tricosane | C23H48 | 11.415 | 0.35 | 91 | NIST | [ |
| 18.250 | 0.89 | 95 | NIST | |||
| 1-Hexacosene | C26H52 | 11.792 | 3.44 | 95 | NIST | [ |